On this episode, we’re reviewing recommendations from the International Association for the Study of Lung Cancer on the use of liquid biopsy for lung cancer. We’ll also hear about a study that compared two regimens added to radiotherapy for pancreatic cancer.

Coverage of stories discussed this week on ascopost.com:

Consensus Statement From IASLC on Liquid Biopsy for Advanced NSCLC

SBRT Plus Pembrolizumab/Trametinib vs Gemcitabine in Locally Recurrent Resected Pancreatic Cancer

To listen to more podcasts from ASCO, visit asco.org/podcasts.